Wound dressings represent a part of the management of diabetic foot ulceration. Ideally, dressings should alleviate symptoms, provide wound protection, and encourage healing. No single dressing fulfills all the requirements of a diabetic patient with an infected foot ulcer. Dressings research in this area is generally poor. However, each category of dressings has particular characteristics that aid selection. Nonadhesive dressings are simple, inexpensive, and well tolerated. Foam and alginate dressings are highly absorbent and effective for heavily exuding wounds. Hydrogels facilitate autolysis and may be beneficial in managing ulcers containing necrotic tissue. Dressings containing inidine and silver may aid in managing wound infection. Occlusive dressings should be avoided for infected wounds. All dressings require frequent change for wound inspection. Heavily exudating ulcers require frequent change to reduce maceration of surrounding skin. Dressing choice should be guided by the characteristics of the ulcer, the requirements of the patient, and costs.
In choosing a dressing for an infected diabetic foot ulcer, several factors have to be taken into account. Infected wounds tend to have a heavy exudate that needs to be controlled to prevent maceration of surrounding tissue. There may be considerable odor associated with infection that may be unpleasant and distressing for the patient and family. A dressing must be comfortable and acceptable for the patient and should help alleviate or, at the very least, not worsen pain, especially at dressing changes. Ideally, the dressing should also aid in the management of the infection itself. Does such a dressing exist? Here, we review currently available dressings that are the most suitable for the infected diabetic foot ulcer.
Desirable characteristics for wound dressings must incorporate the principles of wound healing. For 3 decades, since the work of Winter [1] and Hinman and Maibach [2] , a moist wound environment has been recognized as optimal for healing. Dressings have since been engineered to maintain this environment while also controlling the growth of microorganisms, allowing gaseous exchange, and thermally insulating the wound, which allows atraumatic removal. These dressings must also accommodate practical issues such as allowing observation of the wound and providing mechanical protection and conformability; of course, dressings must also be cost effective [3] . Foster et al. [4] described the ideal dressing for diabetic foot ulcers as follows: it does not take up too much room in the shoe, it performs well in an enclosed environment (shoe) and can withstand shear forces, it does not increase the risk of infection, it absorbs exudates and allows drainage, and it can be changed frequently and easily.
Despite these clearly defined objectives, there is little consensus on which of the many available products is the ideal dressing for infection of the diabetic foot. This is mostly due to a lack of research-based evidence to support the use of one dressing over another. Diabetic patients are often excluded from randomized controlled trials of wound dressings, as are most patients with any wound infection. The few published trials are mostly small case studies, lacking sufficient power to change clinical practice. However, there is no doubt that proper management of infected diabetic foot ulcers should include appropriate antibiotic therapy, regular and thorough wound debridement, and daily dressing changes. It is also imperative to evaluate the arterial and venous status of the affected limb. This will help determine the appropriate medical (and potential surgical) treatment. Table 1 lists classes of dressings and their advantages and disadvantages. Nonadherent or low-adherence dressings. Various types of nonadherent or saline-soaked gauze dressings are often regarded as standard treatment for diabetic ulcers and have usually been used as the control arm in studies of dressings. These dressings are designed to be atraumatic and to provide a moist wound environment. These simple, relatively inexpensive dressings are not designed specifically for managing infection but can be safely used in conjunction with antibiotic treatments.
CLASSES OF DRESSINGS
Hydrocolloids. Hydrocolloid dressings are semipermeable to vapor, occlusive to wound exudate, and absorbent. They are usually presented as an absorbent layer on a film or foam. Examples of commercially available products include Duoderm (Convatec), Granuflex (Convatec), and Comfeel (Coloplast). They were found to be the second most popular choice of dressing (behind nonadherent) for all diabetic foot ulcers in a study of British diabetic specialist nurses and chiropodists [5] . Despite their popularity, their use on infected wounds is controversial. Hydrocolloid materials are designed to be occlusive, trapping exudate within the dressing and hydrating the wound. This creates a hypoxic and moist environment that may also facilitate autolysis of necrotic material. Their use for highly exudative wounds can lead to maceration of the surrounding skin. Concerns persist regarding their use for infected wounds. Some evidence suggests that occlusive dressings may reduce the risk of infection developing in a wound by increasing infiltration of polymorphonuclear leucocytes [6] . Most authorities, however, have expressed concern that hydrocolloids may increase the risk of infection developing within a wound [7] [8] [9] [10] . Hydrocolloid dressings are designed to be left on the wound for prolonged periods (у1 week); this is useful in managing clean ulcers, but not when regular wound inspection is required. Thus, these dressings are probably more useful in preventing, rather than treating, infection within a wound.
Hydrogels. Hydrogels are similar to hydrocolloid dressings in that they are designed to facilitate autolysis of necrotic tissue, but they differ in that they donate moisture to extensively dry wounds. Examples include Aquaform (Maersk Medical) and Intrasite Gel (Smith and Nephew). Thus, they can lead to maceration when applied to wounds that are moderately to heavily exudating. Their use on a diabetic foot lesion should be as an adjunct to sharp debridement of necrotic eschar. Further, they should be applied cautiously on patients with limb ischemia, because dry gangrene could potentially rapidly progress to wet gangrene, with serious consequences. In vitro studies have shown that hydrogels will not support bacterial growth [11] , although a reluctance to apply gels to infected wounds persists.
Foams. Foam-based dressings are another popular choice for diabetic foot ulcers. The dressings have a wide range of absorbency, provide thermal insulation, and are easily cut to shape. Examples include Allevyn (Smith and Nephew) and Cavicare (Smith and Nephew). There have been few published data on their use in diabetic foot ulceration and none on their use in infection. However, their absorbency and comfort would theoretically make them a suitable choice. A new foam dressing (Avance) impregnated with bactericidal silver has recently been introduced.
Alginates. A wide range of different alginate, or seaweed, products are currently available. They are highly absorbent, pack into cavity wounds, provide hemostasis, and are atraumatic at dressing change (but may require wetting). Examples include Kaltostat (Convatec) and Sorbsan (Maersk Medical). It is important to ensure that all dressing is removed from a cavity wound, because retained dressing may be a source for further infection. The dressings may have some bacteriostatic properties. Calcium alginate dressing inhibited growth of Staphylococcus aureus in vitro, with no increase in growth of Pseudomonas, Streptococcus pyogenes, or Bacteroides fragilis [12] . Alginates should be safe to use on infected foot ulcers, provided there are regular and thorough dressing changes.
Iodine preparations. Antiseptics, such as iodine-based preparations, are commonly used on wounds, although there is no evidence to support a beneficial effect. Typically they are applied to locally infected wounds, usually in combination with systemic antibiotics. Iodine comes in 2 main preparations: cadexomer-iodine and povidone-iodine. Iodine is bactericidal in vitro, with maximal activity at 0.1%-1% [13] . Povidone-iodine has long been used as a skin antiseptic, but its antimicrobial effect on wounds is debatable [14, 15] . Furthermore, some data have shown iodine solutions to be toxic to fibroblasts and keratinocytes [16, 17] . A randomized controlled trial of cadexomer-iodine versus saline-soaked gauze on clean foot ulcers showed no significant difference in healing between the groups [18] . Certain iodine dressings are highly absorbent and therefore useful in preventing skin excoriation in moderately exudating ulcers. In our own clinical practice, cadexomer-iodine pastes are used for cavity wounds and povidone-iodine gauze for superficial ulcers. Despite the lack of evidence, many, including ourselves, consider iodine preparations to be appropriate dressings for infected diabetic foot ulcers.
Silver-impregnated dressings. The use of silver as a topical antimicrobial for acute and chronic wounds is well established. It has been traditionally delivered as silver nitrate (on sticks or roll-ons) or as silver sulfadiazine (e.g., Flamazine ointment). Silver nitrate has cytotoxic effects on host cells, a property often exploited in the treatment of hypergranulating tissue, but its application can be uncomfortable. Silver sulfadiazine, which has the antimicrobial actions of both silver and sulfadiazine, is used on burns and chronic wounds and is generally well tolerated.
The antimicrobial effects of silver are complex, including direct inhibition of bacterial cell respiration, inactivation of intracellular enzymes, and alterations to the cell membrane [19] . Silver-coated dressings that use elemental silver may be more efficacious at killing bacteria than is silver sulfadiazine or silver nitrate [20] . New silver-impregnated dressings may be suitable for use for infected diabetic foot ulcers. Examples include Acticoat and Actisorb 220. There have been no randomized controlled clinical trials of these dressings in diabetic foot ulceration. However, reports of accelerated wound reepithelialization [21] and beneficial antibacterial action in the treatment of burns [22] are encouraging.
SUMMARY
A wide array of dressings is now commercially available for treatment of diabetic foot ulcers. New products are frequently being released, each targeted at different aspects of healing. Without clinical trials involving infected ulcers, no evidence can be gathered to differentiate these products. An appropriate dressing will control exudate and odor, alleviate pain, and contain wound infection. Whatever dressing is chosen, there is no substitute for adequate wound debridement, appropriate systemic antibiotic therapy, and frequent (daily) dressing changes and wound inspection.
